Aryeh Jason Insider Trading Activity

Average Profitability
22.85%
Insider Buys Quantity
16
Insider Buys Sum
$937,254.73
Insider Sells Quantity
64
Insider Sells Sum
$40.92M

Insider Activity of Aryeh Jason

According to the SEC Form 4 filings, Aryeh Jason, being in a position of

  1. director at Ligand Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 7111 share for $1.93M,
    over all time since 2007-05-30, has bought 90415 shares for $937,255, and sold 261755 shares for $34.04M.

Biography of Aryeh Jason

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$37,481233
Sells
$1,926,158467

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleLigand Pharmaceuticals Incorporated
LGND
director
700
0.0037%
$320.43$224,298-2.16%
2026-10-30SaleLigand Pharmaceuticals Incorporated
LGND
director
1,411
0.007%
$320.24$451,860
2026-06-11SaleLigand Pharmaceuticals Incorporated
LGND
director
4,500
0.0221%
$250.00$1.13M+16.39%
2026-06-10SaleLigand Pharmaceuticals Incorporated
LGND
director
500
0.0025%
$250.00$125,000+19.35%
2026-05-18PurchaseOrchestra BioMed Holdings, Inc.
OBIO
director
665
0.001%
$3.75$2,494+11.81%
2026-05-15PurchaseOrchestra BioMed Holdings, Inc.
OBIO
director
8,971
0.0157%
$3.90$34,987+19.22%
2025-09-23SaleLigand Pharmaceuticals Incorporated
LGND
director
10,000
0.0511%
$170.81$1.71M+21.77%
2025-09-19PurchaseOrchestra BioMed Holdings, Inc.
OBIO
director
1,000
0.0019%
$2.45$2,450+69.26%
2018-08-17SaleLigand Pharmaceuticals Incorporated
LGND
director
26,862
0.1239%
$241.81$6.5M-49.82%
2018-08-16SaleLigand Pharmaceuticals Incorporated
LGND
director
1,080
0.0052%
$245.00$264,600-48%
2018-03-09SaleLigand Pharmaceuticals Incorporated
LGND
director
4,000
0.0189%
$176.47$705,899-3.05%
2018-03-08SaleLigand Pharmaceuticals Incorporated
LGND
director
3,500
0.0165%
$174.88$612,095-2.08%
2018-02-23SaleLigand Pharmaceuticals Incorporated
LGND
director
3,417
0.0162%
$155.00$529,635+11.33%
2017-11-17SaleLigand Pharmaceuticals Incorporated
LGND
director
24,400
0.1159%
$140.22$3.42M+22%
2017-08-23SaleLigand Pharmaceuticals Incorporated
LGND
director
2,000
0.0096%
$127.99$255,980+23.87%
2017-05-12SaleLigand Pharmaceuticals Incorporated
LGND
director
14,582
0.0687%
$111.87$1.63M+22.54%
2017-05-11SaleLigand Pharmaceuticals Incorporated
LGND
director
22,665
0.1073%
$110.04$2.49M+24.97%
2017-02-28SaleLigand Pharmaceuticals Incorporated
LGND
director
7,000
0.0344%
$107.58$753,060+22.1%
2017-02-27SaleLigand Pharmaceuticals Incorporated
LGND
director
25,000
0.1179%
$106.00$2.65M+18.53%
2016-11-25SaleLigand Pharmaceuticals Incorporated
LGND
director
3,478
0.0167%
$106.96$372,007+6.59%
Total: 51
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.